Literature DB >> 12643601

Expression of survivin and caspase-3 in gastric cancer.

J Kania1, S J Konturek, K Marlicz, E G Hahn, P C Konturek.   

Abstract

Gastric cancer is one of the most common malignant tumors of the gastrointestinal tract. However, the molecular pathways involved in the regulation of gastric carcinogenesis are not completely elucidated. In the last decade, basic cancer research has been focused on the deregulation of apoptosis as a central event in the process of carcinogenesis. Caspase-3 and survivin are regulators of apoptosis and have been implicated in the development of gastric cancer. The aim of the present study was to compare the expression of mRNA and protein for survivin and caspase-3 in the gastric cancer and in the cancer margin with that in normal human gastric mucosa. Fifteen patients with advanced gastric cancer (all H. pylori-positive) and 15 matched control subjects with normal gastric mucosa were included in this study. The biospy specimens for histology and for molecular analyses were taken from gastric tumor, tumor surrounding gastric mucosa and in normal patients from the mucosa of antrum and corpus. Survivin mRNA expression was very weak, but detectable, in the normal gastric mucosa. However, at the protein level, no expression for survivin was detected in the normal gastric mucosa. In the biopsy specimens from tumor and surrounding gastric mucosa, a significant increase in survivin mRNA and protein expression was observed. The expression of survivin was higher in the tumor than in the tumor margin. The mRNA and protein expression of caspase-3 was detected in the gastric mucosa of normal subjects. In gastric cancer only the expression of procaspase-3 was observed, while the expression of active caspase-3 was completely undetectable. In the gastric mucosa surrounding gastric cancer, no gene and protein expression for caspase-3 was detected. We conclude that the changes in the level of caspase-3 and survivin play an important role in the transformation from normal gastric mucosa to gastric career.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12643601     DOI: 10.1023/a:1021915124064

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  16 in total

1.  Survivin gene expression and prognosis in recurrent colorectal cancer.

Authors:  M Miller; D Smith; A Windsor; A Kessling
Journal:  Gut       Date:  2001-01       Impact factor: 23.059

2.  Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas.

Authors:  C D Lu; D C Altieri; N Tanigawa
Journal:  Cancer Res       Date:  1998-05-01       Impact factor: 12.701

3.  Changes in survivin messenger RNA level during cisplatin treatment in gastric cancer.

Authors:  M Ikeguchi; N Kaibara
Journal:  Int J Mol Med       Date:  2001-12       Impact factor: 4.101

4.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

5.  Helicobacter pylori infection and the development of gastric cancer.

Authors:  N Uemura; S Okamoto; S Yamamoto; N Matsumura; S Yamaguchi; M Yamakido; K Taniyama; N Sasaki; R J Schlemper
Journal:  N Engl J Med       Date:  2001-09-13       Impact factor: 91.245

Review 6.  Caspases: key players in programmed cell death.

Authors:  M G Grütter
Journal:  Curr Opin Struct Biol       Date:  2000-12       Impact factor: 6.809

7.  Expression of hepatocyte growth factor, transforming growth factor alpha, apoptosis related proteins Bax and Bcl-2, and gastrin in human gastric cancer.

Authors:  P C Konturek; S J Konturek; Z Sulekova; H Meixner; W Bielanski; T Starzynska; E Karczewska; K Marlicz; J Stachura; E G Hahn
Journal:  Aliment Pharmacol Ther       Date:  2001-07       Impact factor: 8.171

Review 8.  The role of survivin as a new target of diagnosis and treatment in human cancer.

Authors:  T Yamamoto; N Tanigawa
Journal:  Med Electron Microsc       Date:  2001-12

9.  Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients.

Authors:  E Okada; Y Murai; K Matsui; S Isizawa; C Cheng; M Masuda; Y Takano
Journal:  Cancer Lett       Date:  2001-02-10       Impact factor: 8.679

Review 10.  Helicobacter pylori as a risk factor for cancer.

Authors:  P M Webb; D Forman
Journal:  Baillieres Clin Gastroenterol       Date:  1995-09
View more
  26 in total

1.  Combined effect of sCD40L and PI3K siRNA on transplanted tumours growth and microenvironment in nude mice with gastric cancer.

Authors:  Rui Li; Wei-Chang Chen; Xue-Qin Pang; Wen-Yan Tian; Wei-Peng Wang; Xue-Guang Zhang
Journal:  Mol Biol Rep       Date:  2012-06-27       Impact factor: 2.316

2.  Selection of optimal antisense accessible sites of survivin and its application in treatment of gastric cancer.

Authors:  Qiang-Song Tong; Li-Duan Zheng; Fang-Min Chen; Fu-Qing Zeng; Liang Wang; Ji-Hua Dong; Gong-Cheng Lu
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

3.  A functional variant at the miR-885-5p binding site of CASP3 confers risk of both index and second primary malignancies in patients with head and neck cancer.

Authors:  Xiaoxiang Guan; Zhensheng Liu; Hongliang Liu; Hongping Yu; Li-E Wang; Erich M Sturgis; Guojun Li; Qingyi Wei
Journal:  FASEB J       Date:  2012-12-27       Impact factor: 5.191

4.  Inducing Apoptosis and Decreasing Cell Proliferation in Human Acute Promyelocytic Leukemia Through Regulation Expression of CASP3 by Let-7a-5p Blockage.

Authors:  Mahdi Fasihi-Ramandi; Abbas Moridnia; Ali Najafi; Mohammadreza Sharifi
Journal:  Indian J Hematol Blood Transfus       Date:  2017-03-29       Impact factor: 0.900

5.  Survivin expression in early hepatocellular carcinoma and post-treatment with anti-cancer drug under hypoxic culture condition.

Authors:  Satoshi Mamori; Tadashi Asakura; Kiyoshi Ohkawa; Hisao Tajiri
Journal:  World J Gastroenterol       Date:  2007-10-28       Impact factor: 5.742

6.  CASP3 polymorphisms and risk of squamous cell carcinoma of the head and neck.

Authors:  Kexin Chen; Hui Zhao; Zhibin Hu; Li-E Wang; Wei Zhang; Erich M Sturgis; Qingyi Wei
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

7.  PAC-1 activates procaspase-3 in vitro through relief of zinc-mediated inhibition.

Authors:  Quinn P Peterson; David R Goode; Diana C West; Kara N Ramsey; Joy J Y Lee; Paul J Hergenrother
Journal:  J Mol Biol       Date:  2009-03-10       Impact factor: 5.469

8.  Downregulation of survivin by RNAi inhibits growth of human gastric carcinoma cells.

Authors:  Guo-Ying Miao; Qi-Ming Lu; Xiu-Lan Zhang
Journal:  World J Gastroenterol       Date:  2007-02-28       Impact factor: 5.742

9.  Procaspase-3 activation as an anti-cancer strategy: structure-activity relationship of procaspase-activating compound 1 (PAC-1) and its cellular co-localization with caspase-3.

Authors:  Quinn P Peterson; Danny C Hsu; David R Goode; Chris J Novotny; Ryan K Totten; Paul J Hergenrother
Journal:  J Med Chem       Date:  2009-09-24       Impact factor: 7.446

10.  Knockdown of inhibitor of growth protein 2 inhibits cell invasion and enhances chemosensitivity to 5-FU in human gastric cancer cells.

Authors:  Juan Zhong; Lei Yang; Ning Liu; Jun Zheng; Cong-Yao Lin
Journal:  Dig Dis Sci       Date:  2013-07-18       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.